Empowerment program
Not Applicable
- Conditions
- Epilepsy.Epilepsy
- Registration Number
- IRCT2015012720827N1
- Lead Sponsor
- Vice Chancellor for Research of Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
children between 1-12 years old; epilepsy diseases by physicians with pediatric neurologist confirmed; Along with epilepsy disease and not other physical and mental, Exclusion criteria:unwillingness to cooperate in the study of mothers for any reason; the child's death or hospitalization during the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Self-efficacy. Timepoint: 1.5 mounth after intervention. Method of measurement: Steffens RCSES Questionnaire.
- Secondary Outcome Measures
Name Time Method Management of Care self-efficacy. Timepoint: 1.5 months after the intervention. Method of measurement: Steffens RCSES Questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link caregiver empowerment programs to improved maternal self-efficacy in epilepsy management?
How does the IRCT2015012720827N1 empowerment program compare to standard caregiver interventions for pediatric epilepsy?
Are there biomarkers associated with maternal self-efficacy outcomes in epilepsy caregiver intervention trials?
What adverse events are reported in non-pharmacological caregiver empowerment programs for chronic pediatric conditions like epilepsy?
How do combination approaches of empowerment programs with antiepileptic drug therapies affect caregiver and patient outcomes in pediatric epilepsy?